Drug Delivery Devices Market Trends

  • Report ID: 3868
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Drug Delivery Devices Market Trends

Growth Drivers

  • Growing Need for Targeted Drug Delivery- The growing popularity and importance of digital drug delivery systems among enterprises. Nearly 60 percent of employees in a 5000-person company agree that digital drug delivery technology is critical.
  • Growing Technological Advancements- Technological developments in drug delivery systems are expected to make these devices more patient-friendly, easily accessible, and efficient. Phillips-Medisize unveiled its Aria Smart Autoinjector platform in May 2021, enabling breakthroughs, distinction, and long-term viability in the digital drug-delivery device industry.
  • Swift Covid-19 Vaccination Drive Globally- With the worldwide epidemic of COVID-19, most pharmaceutical businesses and governments have been and continue to strive toward providing efficient medical care to COVID-19 patients, and drug delivery devices are likely to play an important role in this context. According to Our World in Data, 3.87 million vaccinations are performed internationally every day, with 12.69 billion doses administered globally.

Challenges

  • Risk of Needle Stick Injuries
  • Increasing Use of Generic Drugs
  • Rigorous Rules and Regulations by the Government The government has implemented severe criteria for product testing to assure the product's effectiveness and security. These rigorous rules and regulations may impede the growth of a novel item or the manufacturing of an existing product. As a result, the factor is anticipated to stifle market expansion.

Drug Delivery Devices Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

5.5%

Base Year Market Size (2023)

USD 284.85 Billion

Forecast Year Market Size (2036)

USD 571.34 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3868
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of drug delivery devices is evaluated at USD 298.95 Billion.

The drug delivery devices market size was valued at USD 284.85 Billion in 2023 and is projected to exceed USD 571.34 Billion by the end of 2036, expanding at over 5.5% CAGR during the forecast period i.e., between 2024-2036. The increasing need for targeted drug delivery to treat cancer is estimated to boost the market growth.

North America industry is set to hold a majority of the share accounted to by 2036, owing to increased product releases and initiatives by leading industry participants.

Antares Pharma, Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Novartis International AG, Johnson & Johnson, GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Abbott Laboratories, Cipla Limited
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying